Show simple item record

dc.contributor.authorMehta, Supriya D.
dc.contributor.authorMoses, Stephen
dc.contributor.authorAgot, Kawango
dc.contributor.authorMaclean, Ian
dc.contributor.authorOdoyo-June, Elijah
dc.contributor.authorLi, Hong
dc.contributor.authorBailey, Robert C.
dc.date.accessioned2013-12-18T19:59:52Z
dc.date.available2014-12-19T10:30:16Z
dc.date.issued2013-12
dc.identifier.bibliographicCitationMehta, S. D., Moses, S., Agot, K., Maclean, I., Odoyo-June, E., Li, H. and Bailey, R. C. Medical Male Circumcision and HSV-2 Acquisition: Post-Trial Surveillance in Kisumu, Kenya.Journal of Infectious Diseases. 2013. doi: 10.1093/infdis/jit371en_US
dc.identifier.issn1537-6613
dc.identifier.urihttp://hdl.handle.net/10027/10936
dc.descriptionThis is a pre-copy-editing, author-produced PDF of an article accepted for publication in Journal of Infectious Diseases following peer review. The definitive publisher-authenticated version: Mehta SD, Moses S, Agot K, Maclean I, Odoyo-June E, Li H, Bailey RC. Medical Male Circumcision and Herpes Simplex Virus 2 Acquisition: Posttrial Surveillance in Kisumu, Kenya. Journal of Infectious Diseases. 2013 Aug 28. is available online at: http://jid.oxfordjournals.org/.en_US
dc.description.abstractBackground. We estimated the 72-month efficacy of medical male circumcision (MMC) against herpes simplex virus 2 (HSV-2) incidence among men in the Kisumu MMC randomized trial.Methods. From 2002 to 2005, 2784 men aged 18-24 were enrolled and randomized 1:1 to immediate circumcision or control. Cox proportional hazards regression incorporating stabilized inverse probability of treatment and censoring weights generated through marginal structural modeling was used to estimate the efficacy of MMC on HSV-2 risk. Conventional conditional Cox regression identified multivariable risks for HSV-2 seroconversion.Results. Among 2044 HSV-2 seronegative men at baseline, the cumulative 72-month HSV-2 incidence was 33.5% (32.7% among circumcised men, 34.6% among uncircumcised men). In weight-adjusted Cox regression, the hazard ratio was 0.88 (95% confidence interval, .77-1.10). In multivariable analyses, risks for HSV-2 included human immunodeficiency virus (HIV) infection, genital ulcer disease (GUD), penile epithelial trauma, multiple recent sex partners, and being married /cohabiting.Conclusions. MMC had no effect on acquisition of HSV-2 during 72 months of follow-up. The temporal sequence and limited correlation between HSV-2, GUD, and penile epithelial trauma suggests that these are distinct phenomena rather than misclassification of HSV-2 symptoms. Determining the etiology of non-sexually transmitted infection GUD and penile epithelial trauma is needed, as both are commonly occurring risks for HSV-2 and HIV acquisition.en_US
dc.description.sponsorshipThis trial was supported by grant number AI50440 from the NIAID, Division of AIDS, NIH; and by grant number HCT 44180 from the Canadian Institutes of Health Research. The trial is registered at http://www.clinical trials.gov under the number NCT0005937. RCB was partially supported by the Chicago Developmental Center for AIDS Research (D-CFAR), an NIH funded program (P30 AI 082151).en_US
dc.language.isoen_USen_US
dc.publisherOxford University Pressen_US
dc.subjectmale circumcisionen_US
dc.subjectHIVen_US
dc.subjectHSV-2en_US
dc.titleMedical Male Circumcision and HSV-2 Acquisition: Post-Trial Surveillance in Kisumu, Kenyaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record